| CTRI Number |
CTRI/2024/07/070131 [Registered on: 07/07/2024] Trial Registered Prospectively |
| Last Modified On: |
11/06/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
A single arm clinical study :efficacy of kalyanaka guda in the management of the irritable bowel syndrome |
|
Scientific Title of Study
|
A single arm clinical study to evaluate the efficacy of kalyanaka guda in the management of irritable bowel syndrome with special reference to vatika grahani |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Mamata Godara |
| Designation |
PG Scholar |
| Affiliation |
National Institute of Ayurveda, Deemed to be University, Jaipur |
| Address |
Department of Kayachikitsa, National Institute of Ayurveda, Deemed
to be University, Near Jorawar Singh gate, Amer Road Jaipur
Jaipur RAJASTHAN 302002 India |
| Phone |
9414930150 |
| Fax |
|
| Email |
mamatagodara98@gmai.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Rashmi Mutha |
| Designation |
Assistant Professor |
| Affiliation |
National Institute of Ayurveda, Deemed to be University, Jaipur |
| Address |
Department of Kayachikitsa, National Institute of Ayurveda, Deemed
to be University, Near Jorawar Singh gate, Amer Road Jaipur
Jaipur RAJASTHAN 302002 India |
| Phone |
9413102151 |
| Fax |
|
| Email |
rashmimutha21@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Rashmi Mutha |
| Designation |
Assistant Professor |
| Affiliation |
National Institute of Ayurveda, Deemed to be University, Jaipur |
| Address |
Department of Kayachikitsa, National Institute of Ayurveda, Deemed
to be University, Near Jorawar Singh gate, Amer Road Jaipur
RAJASTHAN 302002 India |
| Phone |
9413102151 |
| Fax |
|
| Email |
rashmimutha21@yahoo.com |
|
|
Source of Monetary or Material Support
|
| National Institute of ayurved deemed to be university jaipur Rajasthan |
|
|
Primary Sponsor
|
| Name |
National Institute of Ayurveda, Deemed to be University, Jaipur |
| Address |
Near Jorawar Singh gate, Amer Road Jaipur Jaipur RAJASTHAN
302002 India |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Mamata Godara |
Hospital National Institute of Ayurveda, Deemed to be University, Jaipur |
Department of kayachikitsa
OPD No 1, 18, 22, 25
Jaipur RAJASTHAN |
9414930150
mamatagodara98@gmai.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institute Ethics Committee of National institute of Ayurveda, Jaipur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition:K582||Mixed irritable bowel syndrome. Ayurveda Condition: GRAHANIDOSHAH, |
|
|
Intervention / Comparator Agent
|
| sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: kalyanaka guda, Reference: bhaishjaya ratnavali grahani rogadhikar 142-146, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 28 Days, anupAna/sahapAna: Yes(details: lukewarm water), Additional Information: - |
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1.Patients between the age group of 18 to 60 years.
2.Patients irrespective of sex and socio- economic status.
3.Patients having signs and symptoms (abdominal pain and altered bowel habits) of
Irritable Bowel Syndrome and Vatika Grahani like parshvavankshanruk, chiraat dukham drav shushkam tanu..punah punah srujeta varchah.. |
|
| ExclusionCriteria |
| Details |
1. Mixed infection with parasites like round worms, hook worms etc.
2. Patients with bleeding per rectum.
3. Patients with evidence of malignancy.
4. Patients having concomitant illness like hypertension, diabetes mellitus type II,
Amoebic dysentery, Ulcerative colitis, Malabsorption syndrome,
Inflammatory Bowel Diseases & Intestinal tuberculosis, Lactase deficiency
diarrhoea.
5. Patients suffering from major systemic illness like cancer, crohn’s disease, renal
failure etc.
6. Patients who are taking corticosteroids, antidepressants, anticholinergic, or
any other drugs that may have an influence on the outcome of study.
7. Alcoholics and drug abusers.
8. Pregnant and lactating women.
9. Patients who have completed participation in any other clinical trial during the
past six months. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
Changes in the intensity of abdominal pain and altered
bowel habits. |
At baseline and end of 28 days of treatment. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Changes in the other symptoms(Bloating and Weakness)
of IBS.
Changes in quality of life. (QOL SF-36) |
At baseline and end of 28 days of treatment. |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
01/08/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
INTRODUCTION:- Ayurveda the traditional medical practice is playing an inevitable role in maintenance of health and disease prevention despite the era of modern medicine. Grahani dosha described in classical text books of Ayurveda represents a group of disorders of digestive system caused by impairment of Agni. Grahani dosha is such a disorder, wherein its significance is emphasized by its inclusion among Astha Mahagada. Grahani is located above Nabhi (umbilical region) and it is the Adhisthana (seat) of Agni. It is supported and nourished by the strength of Agni. Normally, it receives the ingested food, which is retained by it by restraining the downward movement (Grahanati). After digestion it releases the food through sides of lumen to next Ashaya i.e. Pakvashaya. In abnormal conditions due to weakness of Agni, it gets vitiated and releases food in undigested form. In ayurvedic literature, Grahani is one of the symptom of saman avrit apan vayu. Therefore Irritable bowel syndrome can be considered as a disorder where there is dearrangement of vata in gastrointestinal tract specially of saman vayu and apan vayu leading to symptoms of pain in abdomen and altered bowel habit. Irritable Bowel Syndrome is a functional bowel disorder characterized by abdominal pain or discomfort and altered bowel habits in the absence of detectable structural deformities. Irritable bowel syndrome symptoms tend to come and go over time and often overlap with other functional disorder such as fibromyalgia, headache, backache, and genitourinary symptoms. The pathogenesis of Irritable bowel syndrome is poorly understood, although roles of abnormal gut motor and sensory activity, central neural dysfunction, psychological disturbances, mucosal inflammation, stress and luminal factors have been proposed. On the basis of clinical symptoms of Irritable bowel syndrome we can correlate it with Vatika Grahani in Ayurveda. The symptoms(gastrointestinal) present in Vatika Grahani are chirat mala pravrutti(Pass with difficulty after long time), drav(Liquid),shushkam(Dried), tanu(Thin) aam(Undigested),phenam (Pass with froth),punah punah srujet vrchah(Frequency of stool) etc. No clear diagnostic markers exist for Irritable bowel syndrome thus the diagnosis of the disorder is based on clinical presentation. Spasmolytics, bulking and psychotropic agents are the main conventional pharmacological agents used in the Irritable bowel syndrome management.
AIM: - To assess the effect of Kalyanaka Guda in the management of Irritable Bowel Syndrome with special reference to Vatika Grahani.
OBJECTIVES: - Primary objectives: Evaluation of effect of Kalyanaka Guda on the intensity of abdominal pain and altered bowel habits. Secondary objectives: Evaluation of effect of Kalyanaka Guda on the other symptoms (Bloating and weakness) of IBS with special reference to Vatika Grahani and quality of life ( short form survey -36)
HYPOTHESIS: - NULL HYPOTHESIS(H0):- There is no difference between baseline and after treatment in the intensity of symptoms and quality of life in the patients of IBS with special reference to Vatika Grahani. ALTERNATIVE HYPOTHESIS(H1):- There is a difference between baseline and after treatment in the intensity of symptoms and quality of life in the patients of IBS with special reference to Vatika Grahani.
Study Design:- Phase -2 • Study type-Single center, interventional, single arm, open label • Population-The study will be conducted on clinically diagnosed patients ‘Vatika Grahani’ and Irritable Bowel Syndrome(ROME IV criteria) selected from OPD & IPD of Department of Kayachikitsa, NIA and SSBH, Hospital Jaipur. • Sample- 30 patients • Purpose- To assess the efficacy of the trial drug • Masking- Open label • Timing- Prospective • Endpoint- Efficacy and safety • No. of groups- One • Duration- 28 days(4 weeks) |